INDIANAPOLIS, Nov. 5, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of Jaypirca® (pirtobrutinib), a non-covalent (reversible) Bruton's tyrosine ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

The stock has become a vehicle for Trump’s fans to invest in him figuratively and literally. As Trump Media’s majority ...

In September 2024, Eli Lilly began working with Haya Therapeutics by way of up ... Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 46 ...

The drugs whose labels were updated include Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro ... Compounding group ...

Donald Trump is headed for a second term in the White House. The pundits have had ample opportunity to dissect the political implications of his victory. For this week’s episode of the IBJ Podcast, we ...

Shares of Nvidia rallied to a record high on Thursday, making the chipmaker the first company in history to surpass a stock ...

Past comments by Robert F. Kennedy Jr. hint at the ideas he might advocate for if given a role in the incoming Trump ...

Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...

Shares of Nvidia rallied to a record high on Thursday, making the chipmaker the first company in history to surpass a stock ...

Nvidias stock soared to a staggering $3.65 trillion valuation, surpassing Apple as the worlds most valuable company, driven ...

British homebuilder Persimmon said on Wednesday sales rates since the start of the third quarter were well ahead of last year ...